| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | PRAMEF5 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 2.12e-08 | 55 | 171 | 8 | GO:0042974 |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | PRAMEF5 PRAMEF9 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 3.44e-08 | 82 | 171 | 9 | GO:1990756 |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | PRAMEF5 PRAMEF9 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 1.25e-07 | 95 | 171 | 9 | GO:0140767 |
| GeneOntologyMolecularFunction | glutamate-tRNA ligase activity | 7.29e-05 | 2 | 171 | 2 | GO:0004818 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | PRAMEF5 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 2.14e-04 | 187 | 171 | 8 | GO:0016922 |
| GeneOntologyBiologicalProcess | oocyte development | PRAMEF5 PRAMEF20 PRAMEF15 PRAMEF4 BRCA2 ATM CDC25B PRAMEF11 PRAMEF6 | 1.51e-07 | 99 | 173 | 9 | GO:0048599 |
| GeneOntologyBiologicalProcess | oocyte differentiation | PRAMEF5 PRAMEF20 PRAMEF15 PRAMEF4 BRCA2 ATM CDC25B PRAMEF11 PRAMEF6 | 2.13e-07 | 103 | 173 | 9 | GO:0009994 |
| GeneOntologyBiologicalProcess | female gamete generation | PRAMEF5 USP9X PRAMEF20 PRAMEF15 PRAMEF4 BRCA2 AGT ASPM ATM CDC25B PRAMEF11 PRAMEF6 | 4.18e-07 | 223 | 173 | 12 | GO:0007292 |
| GeneOntologyBiologicalProcess | oogenesis | PRAMEF5 PRAMEF20 PRAMEF15 PRAMEF4 BRCA2 ASPM ATM CDC25B PRAMEF11 PRAMEF6 | 8.11e-07 | 156 | 173 | 10 | GO:0048477 |
| GeneOntologyBiologicalProcess | blastocyst formation | 4.97e-05 | 78 | 173 | 6 | GO:0001825 | |
| GeneOntologyBiologicalProcess | DNA damage response | EPC2 ZBTB38 RTEL1 PPM1D USP9X ZGRF1 USP43 CASP3 BAZ1B EYA1 CEP164 RINT1 MTA1 BRCA2 ATXN7 SYCP1 ZFYVE26 KDM2A ATM DOT1L PML | 5.60e-05 | 959 | 173 | 21 | GO:0006974 |
| GeneOntologyBiologicalProcess | glutamyl-tRNA aminoacylation | 6.99e-05 | 2 | 173 | 2 | GO:0006424 | |
| GeneOntologyBiologicalProcess | gamete generation | PRAMEF5 USP9X SYNE1 PRAMEF20 PRAMEF15 LRRK2 PRAMEF4 SPATA2 LHCGR NLRP14 BRCA2 CCDC34 AGT SYCP1 ASPM ATM TSSK3 CDC25B PIWIL3 PRAMEF11 PRAMEF6 | 7.85e-05 | 982 | 173 | 21 | GO:0007276 |
| GeneOntologyBiologicalProcess | DNA repair | EPC2 RTEL1 USP9X ZGRF1 USP43 EYA1 CEP164 MTA1 BRCA2 ATXN7 SYCP1 ZFYVE26 KDM2A ATM DOT1L PML | 1.17e-04 | 648 | 173 | 16 | GO:0006281 |
| GeneOntologyBiologicalProcess | blastocyst development | PRAMEF5 PRAMEF20 PRAMEF15 PRAMEF4 NLRP9 BRCA2 PRAMEF11 PRAMEF6 | 1.38e-04 | 179 | 173 | 8 | GO:0001824 |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 1.88e-04 | 99 | 173 | 6 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 1.98e-04 | 100 | 173 | 6 | GO:0045103 | |
| GeneOntologyBiologicalProcess | positive regulation of protein autoubiquitination | 2.09e-04 | 3 | 173 | 2 | GO:1902499 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | PRAMEF5 PRAMEF9 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 1.62e-10 | 47 | 174 | 9 | GO:0031462 |
| GeneOntologyCellularComponent | ubiquitin ligase complex | TRAF3 PRAMEF5 PRAMEF9 UBE4B PRAMEF20 FBXL14 PRAMEF15 PRAMEF4 WDR26 KLHL9 BRCA2 FBXL20 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 4.43e-08 | 352 | 174 | 16 | GO:0000151 |
| GeneOntologyCellularComponent | transferase complex | EPC2 RANGAP1 TRAF3 PRAMEF5 PRAMEF9 ACACB UBE4B PRAMEF20 FBXL14 PRAMEF15 PRAMEF4 CHM WDR26 CCNG2 KLHL9 PIGA BRCA2 CCNB3 ATXN7 FBXL20 PRAMEF26 PRAMEF27 TRIM37 PRAMEF11 PRAMEF6 ATG16L2 | 1.17e-07 | 963 | 174 | 26 | GO:1990234 |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | PRAMEF5 PRAMEF9 PRAMEF20 FBXL14 PRAMEF15 PRAMEF4 KLHL9 FBXL20 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 2.24e-07 | 212 | 174 | 12 | GO:0031461 |
| GeneOntologyCellularComponent | intracellular protein-containing complex | EPRS1 EPC2 TRAF3 PRAMEF5 PRAMEF9 UBE4B PRAMEF20 FBXL14 PRAMEF15 PSMD5 PRAMEF4 WDR26 CEP164 KLHL9 BRCA2 ATXN7 FBXL20 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 6.11e-05 | 972 | 174 | 21 | GO:0140535 |
| GeneOntologyCellularComponent | centrosome | DIS3L USP9X DLGAP5 CEP164 LHCGR CCDC88C ODF2L TIAM1 BRCA2 CCNB3 SLMAP ASPM NLRC5 ZFYVE26 ATM CDC25B CCDC116 | 2.48e-04 | 770 | 174 | 17 | GO:0005813 |
| GeneOntologyCellularComponent | microtubule organizing center | DIS3L USP9X DLGAP5 CEP164 LHCGR CCDC88C TTBK2 ODF2L TIAM1 BRCA2 CCNB3 SLMAP ASPM NLRC5 ZFYVE26 ATM CDC25B CCDC116 | 6.77e-04 | 919 | 174 | 18 | GO:0005815 |
| MousePheno | abnormal spermatogonia proliferation | PRAMEF5 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 1.11e-08 | 47 | 131 | 8 | MP:0002685 |
| MousePheno | abnormal male germ cell physiology | PRAMEF5 CYP19A1 PRAMEF20 PRAMEF15 PRAMEF4 LHCGR LRRIQ1 CCDC34 ASPM TSSK3 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 6.71e-08 | 244 | 131 | 14 | MP:0020362 |
| MousePheno | abnormal germ cell physiology | PRAMEF5 CYP19A1 PRAMEF20 PRAMEF15 PRAMEF4 LHCGR LRRIQ1 CCDC34 ASPM TSSK3 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 2.04e-07 | 267 | 131 | 14 | MP:0020363 |
| MousePheno | increased male germ cell apoptosis | PRAMEF5 CYP19A1 PRAMEF20 PRAMEF15 PRAMEF4 LHCGR LRRIQ1 CCDC34 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 2.05e-07 | 189 | 131 | 12 | MP:0014052 |
| MousePheno | decreased germ cell number | PRAMEF5 PPM1D CYP19A1 PRAMEF20 PRAMEF15 PEG3 PRAMEF4 SPATA2 LHCGR BRCA2 AP1G1 CCDC34 SYCP1 ASPM ATM TSSK3 PRAMEF26 PRAMEF27 TRIM37 PRAMEF11 PRAMEF6 | 1.55e-06 | 687 | 131 | 21 | MP:0002209 |
| MousePheno | abnormal jejunum morphology | 2.07e-06 | 41 | 131 | 6 | MP:0004002 | |
| MousePheno | abnormal male germ cell apoptosis | PRAMEF5 CYP19A1 PRAMEF20 PRAMEF15 PRAMEF4 LHCGR LRRIQ1 CCDC34 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 2.19e-06 | 236 | 131 | 12 | MP:0008280 |
| MousePheno | abnormal cecum morphology | EVC2 PRAMEF5 ICA1 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF11 PRAMEF6 | 4.02e-06 | 99 | 131 | 8 | MP:0000494 |
| MousePheno | absent gametes | PRAMEF5 PRAMEF20 PRAMEF15 PRAMEF4 BRCA2 SYCP1 ATM PRAMEF26 PRAMEF27 TRIM37 PRAMEF11 PRAMEF6 | 5.07e-06 | 256 | 131 | 12 | MP:0001117 |
| MousePheno | abnormal sperm number | PRAMEF5 PPM1D CYP19A1 PRAMEF20 PRAMEF15 PRAMEF4 SPATA2 LHCGR BRCA2 AP1G1 CCDC34 SYCP1 ASPM ATM TSSK3 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 5.48e-06 | 624 | 131 | 19 | MP:0002673 |
| MousePheno | abnormal tail morphology | KNTC1 PRAMEF5 SLC26A2 PRAMEF20 PRAMEF15 PRAMEF4 BLMH MTA1 DST EDAR BRCA2 SLMAP DOT1L PRAMEF11 PRAMEF6 | 5.51e-06 | 403 | 131 | 15 | MP:0002111 |
| MousePheno | decreased male germ cell number | PRAMEF5 PPM1D CYP19A1 PRAMEF20 PRAMEF15 PRAMEF4 SPATA2 LHCGR BRCA2 AP1G1 CCDC34 SYCP1 ASPM ATM TSSK3 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 7.87e-06 | 640 | 131 | 19 | MP:0004901 |
| MousePheno | increased kidney weight | PRAMEF5 PRAMEF20 PRAMEF15 LRRK2 PRAMEF4 LHCGR AGT PRAMEF11 PRAMEF6 | 8.76e-06 | 145 | 131 | 9 | MP:0003917 |
| MousePheno | azoospermia | PRAMEF5 PRAMEF20 PRAMEF15 PRAMEF4 BRCA2 SYCP1 ATM PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 1.84e-05 | 244 | 131 | 11 | MP:0005159 |
| MousePheno | abnormal germ cell morphology | PRAMEF5 PPM1D CYP19A1 PRAMEF20 PRAMEF15 PEG3 PRAMEF4 SPATA2 LHCGR BRCA2 AP1G1 CCNB3 CCDC34 SYCP1 ASPM ATM TSSK3 CDC25B PRAMEF26 PRAMEF27 TRIM37 PRAMEF11 PRAMEF6 | 2.12e-05 | 946 | 131 | 23 | MP:0002208 |
| MousePheno | abnormal foam cell morphology | PRAMEF5 PPM1D CYP19A1 PRAMEF20 PRAMEF15 PEG3 PRAMEF4 SPATA2 LHCGR BRCA2 AP1G1 CCNB3 CCDC34 SYCP1 ASPM ATM TSSK3 CDC25B PRAMEF26 PRAMEF27 TRIM37 PRAMEF11 PRAMEF6 | 2.42e-05 | 954 | 131 | 23 | MP:0009840 |
| MousePheno | small testis | PRAMEF5 PPM1D CYP19A1 PRAMEF20 PRAMEF15 PEG3 PRAMEF4 SPATA2 LHCGR CCDC88C NLRP9 BRCA2 SYCP1 ASPM ATM PRAMEF26 PRAMEF27 TRIM37 PRAMEF11 PRAMEF6 PARP12 | 2.51e-05 | 823 | 131 | 21 | MP:0001147 |
| MousePheno | enlarged kidney | PRAMEF5 DIS3L COL27A1 ICA1 PRAMEF20 PRAMEF15 LRRK2 PRAMEF4 LHCGR IL21R AGT PRAMEF11 PRAMEF6 | 2.78e-05 | 354 | 131 | 13 | MP:0003068 |
| MousePheno | abnormal duodenum morphology | 2.90e-05 | 64 | 131 | 6 | MP:0003271 | |
| MousePheno | female infertility | CYP19A1 DLGAP5 EYA1 LHCGR NLRP14 BRCA2 CCNB3 ATXN7 SYCP1 ATM CDC25B TRIM37 PARP12 NLRP5 | 3.01e-05 | 410 | 131 | 14 | MP:0001926 |
| MousePheno | abnormal gametes | PRAMEF5 PPM1D CYP19A1 PRAMEF20 PRAMEF15 PRAMEF4 SPATA2 LHCGR BRCA2 AP1G1 CCDC34 SYCP1 ASPM ATM TSSK3 PRAMEF26 PRAMEF27 TRIM37 PRAMEF11 PRAMEF6 | 4.09e-05 | 785 | 131 | 20 | MP:0001124 |
| MousePheno | decreased testis weight | PRAMEF5 CYP19A1 PRAMEF20 PRAMEF15 PRAMEF4 SPATA2 LHCGR SYCP1 ASPM PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 4.39e-05 | 370 | 131 | 13 | MP:0004852 |
| MousePheno | small gonad | PRAMEF5 PPM1D CYP19A1 PRAMEF20 PRAMEF15 PEG3 PRAMEF4 SPATA2 LHCGR CCDC88C NLRP9 BRCA2 SYCP1 ASPM ATM PRAMEF26 PRAMEF27 TRIM37 PRAMEF11 PRAMEF6 PARP12 | 7.21e-05 | 885 | 131 | 21 | MP:0001116 |
| MousePheno | abnormal testis weight | PRAMEF5 CYP19A1 PRAMEF20 PRAMEF15 PRAMEF4 SPATA2 LHCGR SYCP1 ASPM PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 7.71e-05 | 391 | 131 | 13 | MP:0004850 |
| MousePheno | abnormal primary sex determination | PRAMEF5 PPM1D CYP19A1 PRAMEF20 PRAMEF15 PEG3 PRAMEF4 SPATA2 LHCGR CCDC88C NLRP9 BRCA2 SYCP1 ASPM ATM PRAMEF26 PRAMEF27 TRIM37 PRAMEF11 PRAMEF6 PARP12 | 9.30e-05 | 901 | 131 | 21 | MP:0002211 |
| MousePheno | abnormal auditory brainstem response | PRAMEF5 PRSS12 CYP19A1 PRAMEF20 PRAMEF15 CASP3 DEPDC1 PRAMEF4 EYA1 CCDC88C AP1G1 MYO15A PYCR3 ARHGAP21 PRAMEF11 PRAMEF6 | 9.58e-05 | 576 | 131 | 16 | MP:0004738 |
| MousePheno | infertility | PRAMEF5 PPM1D CYP19A1 PRAMEF20 PRAMEF15 DLGAP5 PRAMEF4 EYA1 LHCGR NLRP14 BRCA2 CCNB3 ATXN7 CCDC34 SYCP1 ATM TSSK3 CDC25B PRAMEF26 PRAMEF27 TRIM37 PRAMEF11 PRAMEF6 PARP12 NLRP5 | 9.67e-05 | 1188 | 131 | 25 | MP:0001924 |
| MousePheno | abnormal hearing physiology | PRAMEF5 PRSS12 CYP19A1 PRAMEF20 PRAMEF15 CASP3 DEPDC1 PRAMEF4 EYA1 CCDC88C AP1G1 ZFYVE26 MYO15A PYCR3 ARHGAP21 PRAMEF11 PRAMEF6 | 1.05e-04 | 643 | 131 | 17 | MP:0001963 |
| MousePheno | enlarged urinary bladder | 1.08e-04 | 116 | 131 | 7 | MP:0011874 | |
| MousePheno | abnormal testis size | PRAMEF5 PPM1D CYP19A1 PRAMEF20 PRAMEF15 PEG3 PRAMEF4 SPATA2 LHCGR CCDC88C NLRP9 BRCA2 SYCP1 ASPM ATM PRAMEF26 PRAMEF27 TRIM37 PRAMEF11 PRAMEF6 PARP12 | 1.16e-04 | 915 | 131 | 21 | MP:0004849 |
| MousePheno | increased circulating amylase level | 1.27e-04 | 119 | 131 | 7 | MP:0008806 | |
| MousePheno | abnormal hearing electrophysiology | PRAMEF5 PRSS12 CYP19A1 PRAMEF20 PRAMEF15 CASP3 DEPDC1 PRAMEF4 EYA1 CCDC88C AP1G1 MYO15A PYCR3 ARHGAP21 PRAMEF11 PRAMEF6 | 1.37e-04 | 594 | 131 | 16 | MP:0006335 |
| MousePheno | abnormal gametogenesis | PRAMEF5 PPM1D CYP19A1 PRAMEF20 PRAMEF15 PEG3 PRAMEF4 SPATA2 LHCGR BRCA2 AP1G1 CCNB3 CCDC34 SYCP1 ASPM ATM TSSK3 CDC25B PRAMEF26 PRAMEF27 TRIM37 PRAMEF11 PRAMEF6 | 1.41e-04 | 1070 | 131 | 23 | MP:0001929 |
| MousePheno | abnormal male germ cell morphology | PRAMEF5 PPM1D CYP19A1 PRAMEF20 PRAMEF15 PRAMEF4 SPATA2 LHCGR BRCA2 AP1G1 CCDC34 SYCP1 ASPM ATM TSSK3 PRAMEF26 PRAMEF27 TRIM37 PRAMEF11 PRAMEF6 | 1.41e-04 | 859 | 131 | 20 | MP:0006362 |
| MousePheno | abnormal kidney weight | PRAMEF5 PRAMEF20 PRAMEF15 LRRK2 PRAMEF4 LHCGR AGT PRAMEF11 PRAMEF6 | 1.48e-04 | 208 | 131 | 9 | MP:0002707 |
| MousePheno | abnormal sex determination | PRAMEF5 PPM1D CYP19A1 PRAMEF20 PRAMEF15 PEG3 PRAMEF4 SPATA2 LHCGR CCDC88C NLRP9 BRCA2 SYCP1 ASPM ATM PRAMEF26 PRAMEF27 TRIM37 PRAMEF11 PRAMEF6 PARP12 | 1.81e-04 | 945 | 131 | 21 | MP:0002210 |
| MousePheno | abnormal ear physiology | PRAMEF5 PRSS12 CYP19A1 PRAMEF20 PRAMEF15 CASP3 DEPDC1 PRAMEF4 EYA1 CCDC88C AP1G1 ZFYVE26 MYO15A PYCR3 ARHGAP21 PRAMEF11 PRAMEF6 | 2.19e-04 | 684 | 131 | 17 | MP:0003878 |
| MousePheno | abnormal testis morphology | PRAMEF5 PPM1D CYP19A1 PRAMEF20 PRAMEF15 PEG3 PRAMEF4 SPATA2 LHCGR CCDC88C NLRP9 BRCA2 SYCP1 ASPM ATM TSSK3 PRAMEF26 PRAMEF27 TRIM37 PRAMEF11 PRAMEF6 PARP12 | 4.29e-04 | 1081 | 131 | 22 | MP:0001146 |
| MousePheno | increased apoptosis | PRAMEF5 NCKAP1 UBE4B CYP19A1 PRAMEF20 PRAMEF15 LRRK2 CASP3 PRAMEF4 EYA1 LHCGR LRRIQ1 EDAR BRCA2 CCDC34 KDM2A DOT1L PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 4.33e-04 | 1008 | 131 | 21 | MP:0006042 |
| MousePheno | abnormal guard hair morphology | 4.97e-04 | 17 | 131 | 3 | MP:0000397 | |
| MousePheno | increased cell death | PRAMEF5 NCKAP1 UBE4B CYP19A1 PRAMEF20 PRAMEF15 LRRK2 CASP3 PRAMEF4 EYA1 LHCGR LRRIQ1 EDAR BRCA2 CCDC34 KDM2A DOT1L PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 5.00e-04 | 1019 | 131 | 21 | MP:0012556 |
| MousePheno | increased fatty acid beta-oxidation | 5.17e-04 | 4 | 131 | 2 | MP:0014173 | |
| MousePheno | abnormal circumvallate papillae morphology | 5.17e-04 | 4 | 131 | 2 | MP:0006258 | |
| MousePheno | abnormal circulating amylase level | 6.62e-04 | 156 | 131 | 7 | MP:0008804 | |
| MousePheno | increased Leydig cell number | 7.48e-04 | 44 | 131 | 4 | MP:0001152 | |
| MousePheno | cataract | EPC2 PRAMEF5 PRAMEF20 PRAMEF15 CASP3 PRAMEF4 EDAR AP1G1 MYO15A PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 7.86e-04 | 497 | 131 | 13 | MP:0001304 |
| MousePheno | abnormal spermatogenesis | PRAMEF5 PPM1D CYP19A1 PRAMEF20 PRAMEF15 PRAMEF4 SPATA2 LHCGR BRCA2 AP1G1 CCDC34 SYCP1 ASPM ATM TSSK3 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 8.12e-04 | 910 | 131 | 19 | MP:0001156 |
| MousePheno | abnormal male reproductive gland morphology | DMTF1 PRAMEF5 KRT27 PPM1D CYP19A1 PRAMEF20 PRAMEF15 PEG3 PRAMEF4 SPATA2 LHCGR CCDC88C NLRP9 BRCA2 SYCP1 ASPM ATM TSSK3 PRAMEF26 PRAMEF27 TRIM37 PRAMEF11 PRAMEF6 PARP12 | 8.35e-04 | 1290 | 131 | 24 | MP:0013325 |
| MousePheno | abnormal seminal vesicle morphology | DMTF1 PRAMEF5 KRT27 CYP19A1 PRAMEF20 PRAMEF15 PRAMEF4 LHCGR PRAMEF11 PRAMEF6 | 8.39e-04 | 319 | 131 | 10 | MP:0002059 |
| Domain | - | NLRP12 RANGAP1 PRAMEF25 PRAMEF5 PRAMEF20 FBXL14 PRAMEF15 LRRK2 LRRC40 PRAMEF4 LRRC30 LRRC47 LRRC55 LHCGR NLRP9 NLRP14 LRRIQ1 NLRC5 KDM2A LRRC14 FBXL20 PRAMEF27 PRAMEF6 NLRP5 | 1.69e-15 | 321 | 169 | 24 | 3.80.10.10 |
| Domain | L_dom-like | NLRP12 RANGAP1 PRAMEF25 PRAMEF5 PRAMEF20 FBXL14 PRAMEF15 LRRK2 LRRC40 PRAMEF4 LRRC30 LRRC47 LRRC55 LHCGR NLRP9 NLRP14 LRRIQ1 NLRC5 KDM2A LRRC14 FBXL20 PRAMEF27 PRAMEF6 NLRP5 | 2.75e-15 | 328 | 169 | 24 | IPR032675 |
| Domain | PRAME_family | 2.02e-10 | 19 | 169 | 7 | IPR026271 | |
| Domain | LRR_6 | NLRP12 RANGAP1 FBXL14 NLRP9 NLRP14 NLRC5 LRRC14 FBXL20 NLRP5 | 1.46e-09 | 55 | 169 | 9 | PF13516 |
| Domain | Leu-rich_rpt | NLRP12 RANGAP1 FBXL14 LRRK2 LRRC40 LRRC30 LRRC47 LRRC55 NLRP9 NLRP14 LRRIQ1 NLRC5 KDM2A LRRC14 FBXL20 NLRP5 | 3.47e-09 | 271 | 169 | 16 | IPR001611 |
| Domain | NACHT | 4.46e-08 | 23 | 169 | 6 | PS50837 | |
| Domain | NACHT_NTPase | 4.46e-08 | 23 | 169 | 6 | IPR007111 | |
| Domain | LRR_1 | RANGAP1 FBXL14 LRRK2 LRRC40 LRRC30 LRRC47 LRRC55 LRRIQ1 NLRC5 KDM2A LRRC14 FBXL20 | 7.55e-07 | 219 | 169 | 12 | PF00560 |
| Domain | Leu-rich_rpt_Cys-con_subtyp | 2.26e-05 | 19 | 169 | 4 | IPR006553 | |
| Domain | LRR_CC | 2.26e-05 | 19 | 169 | 4 | SM00367 | |
| Domain | DEATH-like_dom | 3.25e-05 | 99 | 169 | 7 | IPR011029 | |
| Domain | DAPIN | 4.17e-05 | 22 | 169 | 4 | PS50824 | |
| Domain | PYRIN | 4.17e-05 | 22 | 169 | 4 | SM01289 | |
| Domain | PYRIN | 4.17e-05 | 22 | 169 | 4 | PF02758 | |
| Domain | DAPIN | 4.17e-05 | 22 | 169 | 4 | IPR004020 | |
| Domain | ARM-like | 1.80e-04 | 270 | 169 | 10 | IPR011989 | |
| Domain | - | 2.00e-04 | 93 | 169 | 6 | 1.10.533.10 | |
| Domain | tRNA-synt_1c | 2.43e-04 | 3 | 169 | 2 | PF00749 | |
| Domain | Glu/Gln-tRNA-synth_Ib_a-bdl | 2.43e-04 | 3 | 169 | 2 | IPR020061 | |
| Domain | - | 2.43e-04 | 3 | 169 | 2 | 1.10.1160.10 | |
| Domain | Glu/Gln-tRNA-synth_Ib_cat-dom | 2.43e-04 | 3 | 169 | 2 | IPR020058 | |
| Domain | Glu/Gln-tRNA-synth | 2.43e-04 | 3 | 169 | 2 | IPR000924 | |
| Domain | NPIP | 2.46e-04 | 14 | 169 | 3 | IPR009443 | |
| Domain | ARM-type_fold | DOCK8 USP9X LRRK2 PSMD5 IPO4 AP1G1 CEBPZ ASPM ATM LRBA AGBL1 | 2.70e-04 | 339 | 169 | 11 | IPR016024 |
| Domain | Filament | 4.60e-04 | 71 | 169 | 5 | SM01391 | |
| Domain | IF | 4.90e-04 | 72 | 169 | 5 | PS00226 | |
| Domain | LRR | 4.98e-04 | 201 | 169 | 8 | PS51450 | |
| Domain | Filament | 5.23e-04 | 73 | 169 | 5 | PF00038 | |
| Domain | IF | 6.29e-04 | 76 | 169 | 5 | IPR001664 | |
| Domain | Keratin_I | 6.62e-04 | 44 | 169 | 4 | IPR002957 | |
| Pubmed | NLRP12 PRAMEF5 PRAMEF20 PRAMEF15 PRAMEF4 NLRP9 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 NLRP5 | 1.11e-18 | 28 | 181 | 11 | 25089626 | |
| Pubmed | DMTF1 EPRS1 PRAMEF5 RSL1D1 ICA1 PRAMEF20 PRAMEF15 PEG3 DLGAP5 FRMPD1 BAZ1B GEMIN5 DEPDC1 PRAMEF4 TTBK2 C5orf34 MTA1 GBP4 AP1G1 ANKRD12 DOT1L BAIAP3 TRIM37 ARHGAP21 MINDY1 PRAMEF11 PRAMEF6 FHIP2B PARP12 PML | 7.75e-14 | 1084 | 181 | 30 | 11544199 | |
| Pubmed | PRAMEF5 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 1.38e-13 | 22 | 181 | 8 | 31729367 | |
| Pubmed | PRAMEF5 PRAMEF20 PRAMEF15 PRAMEF4 MTA1 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 1.44e-13 | 35 | 181 | 9 | 19389355 | |
| Pubmed | PRAMEF5 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 4.62e-13 | 25 | 181 | 8 | 37451217 | |
| Pubmed | 6.74e-12 | 20 | 181 | 7 | 26694250 | ||
| Pubmed | PRAMEF5 PRAMEF20 PRAMEF15 PEG3 CASP3 PRAMEF4 PRAMEF11 PRAMEF6 | 1.02e-10 | 46 | 181 | 8 | 17287250 | |
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 2.16e-10 | 17 | 181 | 6 | 23565261 | |
| Pubmed | 2.16e-10 | 17 | 181 | 6 | 37781892 | ||
| Pubmed | 3.22e-10 | 18 | 181 | 6 | 23894331 | ||
| Pubmed | Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation. | 3.22e-10 | 18 | 181 | 6 | 39181896 | |
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 3.22e-10 | 18 | 181 | 6 | 12890732 | |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 3.22e-10 | 18 | 181 | 6 | 29731491 | |
| Pubmed | 3.22e-10 | 18 | 181 | 6 | 14675769 | ||
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 4.69e-10 | 19 | 181 | 6 | 28604677 | |
| Pubmed | 6.67e-10 | 20 | 181 | 6 | 16580637 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 6.67e-10 | 20 | 181 | 6 | 21425410 | |
| Pubmed | 1.71e-09 | 23 | 181 | 6 | 19480014 | ||
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 2.98e-09 | 25 | 181 | 6 | 12620990 | |
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 3.86e-09 | 26 | 181 | 6 | 18500982 | |
| Pubmed | Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice. | 9.79e-09 | 30 | 181 | 6 | 38786026 | |
| Pubmed | LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance. | 1.48e-08 | 32 | 181 | 6 | 37889087 | |
| Pubmed | PRAMEF5 ICA1 PRAMEF20 PRAMEF15 PRAMEF4 NLRP9 NLRP14 SLMAP ASPM PRAMEF11 PRAMEF6 NLRP5 | 1.63e-07 | 326 | 181 | 12 | 17015433 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 2.40e-07 | 50 | 181 | 6 | 31806660 | |
| Pubmed | 3.40e-07 | 12 | 181 | 4 | 15617563 | ||
| Pubmed | 5.91e-07 | 58 | 181 | 6 | 31598710 | ||
| Pubmed | 6.55e-07 | 59 | 181 | 6 | 11279525 | ||
| Pubmed | 6.82e-07 | 14 | 181 | 4 | 20403135 | ||
| Pubmed | 6.82e-07 | 14 | 181 | 4 | 12563287 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 RANGAP1 NCKAP1 UBE4B RSL1D1 DLGAP5 BAZ1B GEMIN5 PSMD5 LRRC40 IPO4 LRRC47 BLMH DST AP1G1 CEBPZ ASPM NUP133 KDM2A KIF18B PYCR3 PARP12 | 2.42e-06 | 1353 | 181 | 22 | 29467282 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | RANGAP1 GRIPAP1 ACACB NCKAP1 DIS3L SPATA2 CEP164 CCDC88C ODF2L RINT1 KLHL9 BRCA2 TRIM37 ARHGAP21 KLC1 FHIP2B BORA | 2.63e-06 | 853 | 181 | 17 | 28718761 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KNTC1 GRIPAP1 PPM1D USP9X ZGRF1 BAZ1B IPO4 ODF2L BRCA2 ASPM HELZ DOT1L TRIM37 PML | 2.80e-06 | 588 | 181 | 14 | 38580884 |
| Pubmed | 4.17e-06 | 234 | 181 | 9 | 36243803 | ||
| Pubmed | KNTC1 ACACB NCKAP1 RUNDC3B DOCK8 USP9X CCDC88C DST SLMAP HELZ TRIM37 SNTB2 | 4.32e-06 | 446 | 181 | 12 | 24255178 | |
| Pubmed | 9.00e-06 | 92 | 181 | 6 | 20301317 | ||
| Pubmed | RANGAP1 NCKAP1 RSL1D1 USP9X BAZ1B GEMIN5 IPO4 TASOR2 LRRC47 DST CEBPZ NUP133 HELZ ATM | 9.23e-06 | 653 | 181 | 14 | 22586326 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | EPRS1 RANGAP1 NCKAP1 UBE4B EARS2 USP9X CASP3 LRRC40 IPO4 EXOC8 LRRC47 CNNM4 RINT1 AP1G1 CEBPZ NUP133 MINDY1 | 9.66e-06 | 942 | 181 | 17 | 31073040 |
| Pubmed | KNTC1 GRIPAP1 RTEL1 DIS3L COL27A1 FCHO1 CCDC88C CNNM4 VPS13D DSTYK KDM2A LRRC14 | 1.18e-05 | 493 | 181 | 12 | 15368895 | |
| Pubmed | EPRS1 ZBTB38 UBE4B DIS3L RSL1D1 USP9X SYNE1 PEG3 HECTD4 PSMD5 WDR26 ODF2L MTA1 DST TIAM1 ASB3 ATM LRBA TRIM37 ARHGAP21 | 1.35e-05 | 1285 | 181 | 20 | 35914814 | |
| Pubmed | 1.99e-05 | 63 | 181 | 5 | 16831889 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | PRAMEF5 ZGRF1 PRAMEF20 PRAMEF15 HECTD4 PRAMEF4 DST ASPM PRAMEF11 PRAMEF6 | 2.26e-05 | 363 | 181 | 10 | 14691545 |
| Pubmed | Characterization of long cDNA clones from human adult spleen. | 2.58e-05 | 33 | 181 | 4 | 11214971 | |
| Pubmed | PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins. | 2.69e-05 | 2 | 181 | 2 | 16818720 | |
| Pubmed | Wip1 phosphatase modulates ATM-dependent signaling pathways. | 2.69e-05 | 2 | 181 | 2 | 16949371 | |
| Pubmed | Molecular mechanisms underlying the role of the centriolar CEP164-TTBK2 complex in ciliopathies. | 2.69e-05 | 2 | 181 | 2 | 34499853 | |
| Pubmed | Absence of Wip1 partially rescues Atm deficiency phenotypes in mice. | 2.69e-05 | 2 | 181 | 2 | 21765465 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 37126020 | ||
| Pubmed | Caspase-mediated cleavage of TRAF3 in FasL-stimulated Jurkat-T cells. | 2.69e-05 | 2 | 181 | 2 | 11261798 | |
| Pubmed | Wip1 controls global heterochromatin silencing via ATM/BRCA1-dependent DNA methylation. | 2.69e-05 | 2 | 181 | 2 | 24135283 | |
| Pubmed | Cleavage of bleomycin hydrolase by caspase-3 during apoptosis. | 2.69e-05 | 2 | 181 | 2 | 23708668 | |
| Pubmed | Extreme Response to High-dose Testosterone in BRCA2- and ATM-mutated Prostate Cancer. | 2.69e-05 | 2 | 181 | 2 | 27692705 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 34533610 | ||
| Pubmed | Cep164 triggers ciliogenesis by recruiting Tau tubulin kinase 2 to the mother centriole. | 2.69e-05 | 2 | 181 | 2 | 24982133 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 37845585 | ||
| Pubmed | Down-regulation of CIBZ, a novel substrate of caspase-3, induces apoptosis. | 2.69e-05 | 2 | 181 | 2 | 18375381 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPRS1 RANGAP1 ACACB RSL1D1 DLGAP5 CASP3 BAZ1B GEMIN5 DST NUP133 HELZ LRBA ARHGAP21 KLC1 PARP12 PML | 3.34e-05 | 934 | 181 | 16 | 33916271 |
| Pubmed | RANGAP1 EARS2 RSL1D1 UNC5B SYNE1 BAZ1B LRRC40 IPO4 LRRC47 RINT1 C5orf34 TIAM1 CEBPZ SLMAP ASPM NUP133 ATM PYCR3 SNTB2 KLC1 PML | 3.42e-05 | 1487 | 181 | 21 | 33957083 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | KNTC1 EPRS1 RANGAP1 NCKAP1 RSL1D1 USP9X ICA1 IPO4 CNNM4 TTBK2 TIAM1 DSTYK ASB3 SLMAP ASPM NUP133 LRBA CDC25B KLC1 | 4.45e-05 | 1284 | 181 | 19 | 17353931 |
| Pubmed | UBE4B USP9X PEG3 HECTD4 PSMD5 SPATA2 FCHO1 DST SLMAP PYCR3 PML | 4.82e-05 | 481 | 181 | 11 | 28190767 | |
| Pubmed | 5.18e-05 | 183 | 181 | 7 | 23956138 | ||
| Pubmed | 5.35e-05 | 250 | 181 | 8 | 33536335 | ||
| Pubmed | FBXL13 directs the proteolysis of CEP192 to regulate centrosome homeostasis and cell migration. | 6.80e-05 | 42 | 181 | 4 | 29348145 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | UBE4B FBXL14 HECTD4 TRMT11 GEMIN5 TEP1 CCDC88C LIME1 SLC8B1 DST CCDC34 NLRC5 ZFYVE26 LRRC14 LRBA DOT1L ARHGAP21 | 7.14e-05 | 1105 | 181 | 17 | 35748872 |
| Pubmed | EPRS1 RSL1D1 USP9X CYP19A1 DLGAP5 GEMIN5 IPO4 MTA1 NUP133 SNTB2 KLC1 | 7.19e-05 | 503 | 181 | 11 | 16964243 | |
| Pubmed | 7.37e-05 | 418 | 181 | 10 | 34709266 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | RANGAP1 USP43 TRMT11 IPO4 SPATA2 WDR26 EXOC8 LRRC47 BLMH KLHL9 SLMAP LRRC14 CDC25B PYCR3 SNTB2 BORA | 7.90e-05 | 1005 | 181 | 16 | 19615732 |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 15590904 | ||
| Pubmed | BRCA2 is required for neurogenesis and suppression of medulloblastoma. | 8.05e-05 | 3 | 181 | 2 | 17476307 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 15084244 | ||
| Pubmed | Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland. | 8.05e-05 | 3 | 181 | 2 | 32875559 | |
| Pubmed | The sex distribution of waved-2, shaker-2 and Rex in the house mouse. | 8.05e-05 | 3 | 181 | 2 | 13170359 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 20093417 | ||
| Pubmed | ATM/Wip1 activities at chromatin control Plk1 re-activation to determine G2 checkpoint duration. | 8.05e-05 | 3 | 181 | 2 | 28607002 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 12207967 | ||
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 31959038 | ||
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 23656780 | ||
| Pubmed | Radiation enhances caspase 3 cleavage of Rad51 in BRCA2-defective cells. | 8.05e-05 | 3 | 181 | 2 | 18439040 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 33414135 | ||
| Pubmed | Oocytes progress beyond prophase in the presence of DNA damage. | 8.05e-05 | 3 | 181 | 2 | 22578416 | |
| Pubmed | Complementary functions of ATM and H2AX in development and suppression of genomic instability. | 8.05e-05 | 3 | 181 | 2 | 18599436 | |
| Pubmed | Screening for ATM sequence alterations in African-American women diagnosed with breast cancer. | 8.05e-05 | 3 | 181 | 2 | 17333338 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 16874310 | ||
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 26505164 | ||
| Pubmed | Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. | 8.05e-05 | 3 | 181 | 2 | 16574953 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 22503542 | ||
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 34517749 | ||
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 15474461 | ||
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 29915322 | ||
| Pubmed | DNA Repair Deficiency Is Common in Advanced Prostate Cancer: New Therapeutic Opportunities. | 8.05e-05 | 3 | 181 | 2 | 27317574 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 25297623 | ||
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 25428203 | ||
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 31276164 | ||
| Pubmed | Divergent origins and concerted expansion of two segmental duplications on chromosome 16. | 8.05e-05 | 3 | 181 | 2 | 11948212 | |
| Pubmed | Expression of mRNA for the LH and FSH receptors in mouse oocytes and preimplantation embryos. | 8.05e-05 | 3 | 181 | 2 | 11226072 | |
| Pubmed | 8.05e-05 | 3 | 181 | 2 | 17341485 | ||
| Pubmed | A threshold concentration of FSH is needed during IVM of ex vivo collected human oocytes. | 8.05e-05 | 3 | 181 | 2 | 34050448 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | RANGAP1 NCKAP1 UBE4B CASP3 BAZ1B PSMD5 IPO4 LRRC47 AP1G1 CEBPZ NUP133 LRBA KLC1 | 8.88e-05 | 704 | 181 | 13 | 29955894 |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | EPC2 PRAMEF5 EARS2 PRAMEF20 PRAMEF15 BAZ1B PRAMEF4 CCDC122 AMZ2 MTA1 ASPM DOT1L KIF18B MYO15A MINDY1 PRAMEF11 PRAMEF6 ATG16L2 | 9.26e-05 | 1242 | 181 | 18 | 30973865 |
| Pubmed | 1.22e-04 | 210 | 181 | 7 | 16565220 | ||
| Pubmed | EPRS1 RANGAP1 NCKAP1 USP9X GEMIN5 LRRC40 IPO4 WDR26 LRRC47 AP1G1 NUP133 LRBA | 1.40e-04 | 638 | 181 | 12 | 33239621 | |
| Interaction | PRAMEF4 interactions | 5.69e-07 | 3 | 168 | 3 | int:PRAMEF4 | |
| Interaction | KRT74 interactions | 1.33e-05 | 37 | 168 | 5 | int:KRT74 | |
| Cytoband | 1p36.21 | PRAMEF25 PRAMEF5 PRAMEF9 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF11 PRAMEF6 | 3.71e-12 | 63 | 181 | 9 | 1p36.21 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | PRAMEF25 PRAMEF5 PRAMEF9 UBE4B PRAMEF20 PRAMEF15 PRAMEF4 LRRC47 VPS13D PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 3.57e-06 | 681 | 181 | 13 | chr1p36 |
| Cytoband | 16p12.2 | 1.39e-05 | 37 | 181 | 4 | 16p12.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 6.62e-05 | 172 | 181 | 6 | chr16p12 | |
| Cytoband | 14q32.3 | 6.81e-04 | 10 | 181 | 2 | 14q32.3 | |
| Cytoband | Xp11 | 6.81e-04 | 10 | 181 | 2 | Xp11 | |
| Cytoband | 8q13.2 | 8.31e-04 | 11 | 181 | 2 | 8q13.2 | |
| GeneFamily | PRAME family | PRAMEF25 PRAMEF5 PRAMEF9 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 1.10e-16 | 24 | 113 | 10 | 686 |
| GeneFamily | NLR family | 4.19e-07 | 25 | 113 | 5 | 666 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 1.65e-05 | 25 | 113 | 4 | 994 | |
| GeneFamily | Keratins, type I | 2.64e-05 | 28 | 113 | 4 | 608 | |
| GeneFamily | PDZ domain containing | 4.74e-05 | 152 | 113 | 7 | 1220 | |
| GeneFamily | F-box and leucine rich repeat proteins | 2.91e-04 | 21 | 113 | 3 | 558 | |
| GeneFamily | Zinc fingers GRF-type|Topoisomerases | 7.97e-04 | 7 | 113 | 2 | 135 | |
| GeneFamily | UPF1 like RNA helicases | 2.05e-03 | 11 | 113 | 2 | 1169 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | KNTC1 RANGAP1 RTEL1 RUNDC3B ZGRF1 DLGAP5 CASP3 LRRC40 DEPDC1 KCNB2 FCHO1 ODF2L BRCA2 SERTAD4 ASPM DOT1L KIF18B CDC25B TRIM37 BORA | 4.78e-08 | 680 | 179 | 20 | MM456 |
| Coexpression | KOHOUTEK_CCNT2_TARGETS | PRAMEF5 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 8.51e-08 | 81 | 179 | 8 | MM938 |
| Coexpression | KINNEY_DNMT1_METHYLATION_TARGETS | 1.07e-07 | 34 | 179 | 6 | MM955 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED | 1.22e-07 | 57 | 179 | 7 | MM1262 | |
| Coexpression | MORI_SMALL_PRE_BII_LYMPHOCYTE_UP | PRAMEF5 PRAMEF20 PRAMEF15 PRAMEF4 CCNG2 CYB5R4 PRAMEF11 PRAMEF6 | 3.77e-07 | 98 | 179 | 8 | MM592 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | KNTC1 RANGAP1 ZGRF1 DLGAP5 CASP3 DEPDC1 CCDC122 ODF2L BRCA2 CCDC34 ASPM KIF18B CDC25B BORA | 7.60e-07 | 402 | 179 | 14 | MM454 |
| Coexpression | GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN | CCDC88C RINT1 TIAM1 HELZ ZFYVE26 FBXL20 BAIAP3 METTL22 FHIP2B PML | 1.26e-06 | 200 | 179 | 10 | M6208 |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | RANGAP1 RTEL1 RSL1D1 DLGAP5 CASP3 LRRC40 DEPDC1 ERI2 CCNG2 BRCA2 CCDC34 ASPM NUP133 LRRC14 KIF18B PYCR3 PML BORA | 2.13e-06 | 714 | 179 | 18 | M1744 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | KNTC1 RANGAP1 PEG3 DLGAP5 CASP3 GEMIN5 DEPDC1 ERI2 BRCA2 CCDC34 SERTAD4 ASPM NUP133 KIF18B CDC25B BORA | 2.47e-06 | 578 | 179 | 16 | M2368 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | KNTC1 RANGAP1 PEG3 DLGAP5 CASP3 GEMIN5 DEPDC1 ERI2 BRCA2 CCDC34 SERTAD4 ASPM NUP133 KIF18B CDC25B BORA | 3.73e-06 | 597 | 179 | 16 | MM1309 |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_ADDNL_EXON_LVL_UP | 3.82e-06 | 94 | 179 | 7 | M40880 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 4.33e-06 | 180 | 179 | 9 | M8239 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS | PRAMEF5 PRAMEF20 PRAMEF15 BAZ1B PRAMEF4 PIGA PLD2 PRAMEF11 PRAMEF6 | 4.33e-06 | 180 | 179 | 9 | MM612 |
| Coexpression | DESCARTES_ORGANOGENESIS_SCHWANN_CELL_PRECURSOR | 5.05e-06 | 98 | 179 | 7 | MM3656 | |
| Coexpression | SANSOM_APC_TARGETS | PRAMEF5 DIS3L PRAMEF20 PRAMEF15 PRAMEF4 TTBK2 TIAM1 PRAMEF11 PRAMEF6 ATG16L2 | 7.68e-06 | 245 | 179 | 10 | MM735 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | KNTC1 EPRS1 ZBTB38 USP9X DLGAP5 BAZ1B NPIPB3 LRRC40 DEPDC1 FAM13B TASOR2 RINT1 CEBPZ SLMAP ASPM ATM | 1.21e-05 | 656 | 179 | 16 | M18979 |
| Coexpression | INGRAM_SHH_TARGETS_UP | PRAMEF5 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 1.24e-05 | 156 | 179 | 8 | MM550 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | KNTC1 RANGAP1 ZGRF1 DLGAP5 USP43 DEPDC1 C5orf34 BRCA2 CCDC34 ASPM KIF18B CDC25B HDC BORA | 3.78e-05 | 567 | 179 | 14 | M45692 |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 5.11e-05 | 190 | 179 | 8 | M761 | |
| Coexpression | HUANG_GATA2_TARGETS_DN | 5.84e-05 | 98 | 179 | 6 | MM942 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | 5.91e-05 | 194 | 179 | 8 | M7467 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN | 6.13e-05 | 195 | 179 | 8 | M7410 | |
| Coexpression | GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP | 7.07e-05 | 199 | 179 | 8 | M3217 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_BCELL_DN | 7.32e-05 | 200 | 179 | 8 | M8261 | |
| Coexpression | GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_UP | 7.32e-05 | 200 | 179 | 8 | M6551 | |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | PRAMEF5 ICA1 PRAMEF20 PRAMEF15 PRAMEF4 CCNG2 CEBPZ ATM PRAMEF11 PRAMEF6 HDC PML | 8.70e-05 | 463 | 179 | 12 | MM1011 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | KNTC1 RANGAP1 PPM1D ZGRF1 DLGAP5 BAZ1B LRRC40 DEPDC1 BRCA2 CCDC34 ASPM KIF18B SNTB2 ATG16L2 BORA | 8.96e-05 | 694 | 179 | 15 | M45767 |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 1.50e-04 | 166 | 179 | 7 | M8129 | |
| Coexpression | ZHONG_PFC_C2_UNKNOWN_NPC | 1.75e-04 | 76 | 179 | 5 | M39087 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL | 1.81e-04 | 290 | 179 | 9 | M45736 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_DN | PRAMEF5 PRAMEF20 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF11 PRAMEF6 | 2.04e-04 | 232 | 179 | 8 | MM1019 |
| Coexpression | NUYTTEN_EZH2_TARGETS_DN | KNTC1 DIS3L DOCK8 SLC26A2 ZGRF1 DLGAP5 BAZ1B DEPDC1 FCHO1 AMZ2 C5orf34 KLHL9 BRCA2 ASPM KIF18B TRIM37 PYCR3 BORA | 2.37e-04 | 1023 | 179 | 18 | M17122 |
| Coexpression | JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN | KNTC1 GRIPAP1 NPIPB12 ICA1 DLGAP5 NPIPB3 LIME1 NPIPB13 MINDY1 | 2.44e-04 | 302 | 179 | 9 | M38975 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | KNTC1 EPRS1 EARS2 RSL1D1 ZGRF1 COL27A1 DLGAP5 BAZ1B LRRC40 DEPDC1 FAM200A BLMH RINT1 C5orf34 ZNF547 GBP4 BRCA2 ASB3 ASPM NUP133 KIF18B PARP12 | 2.53e-04 | 1407 | 179 | 22 | M14427 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | EPC2 RTEL1 RSL1D1 PPM1D USP9X ZGRF1 CASP3 BAZ1B DEPDC1 ERI2 CCDC88C PSTK ODF2L BRCA2 CCDC34 SLMAP ASPM ATM TRIM37 ARHGAP21 MINDY1 METTL22 FHIP2B BORA | 1.77e-05 | 1257 | 157 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | EPC2 RTEL1 RSL1D1 PPM1D USP9X ZGRF1 CASP3 BAZ1B DEPDC1 ERI2 PREX2 CCDC88C PSTK ODF2L KCNQ5 BRCA2 CCDC34 SLMAP ASPM ATM TRIM37 ARHGAP21 MINDY1 METTL22 FHIP2B BORA | 2.51e-05 | 1459 | 157 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | KNTC1 ZGRF1 DLGAP5 DEPDC1 ERI2 CCNG2 BRCA2 CCDC34 ASPM KIF18B CDC25B BORA | 4.22e-05 | 398 | 157 | 12 | GSM399397_500 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | KNTC1 ZGRF1 DLGAP5 DEPDC1 EYA1 ERI2 BRCA2 CCDC34 ASPM KIF18B CDC25B BORA | 5.48e-05 | 409 | 157 | 12 | GSM399452_500 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-08 | 175 | 181 | 9 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.59e-08 | 180 | 181 | 9 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.67e-08 | 131 | 181 | 8 | 419a0a83b38eaea890d065c3f252ef83c2d37b5b | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.49e-08 | 189 | 181 | 9 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.02e-07 | 193 | 181 | 9 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.32e-07 | 199 | 181 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.37e-07 | 200 | 181 | 9 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.37e-07 | 200 | 181 | 9 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.40e-07 | 172 | 181 | 8 | 7f3d0ef18f5df1ed80498d435b0378ca398c0b88 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.89e-07 | 174 | 181 | 8 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.15e-07 | 175 | 181 | 8 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.15e-07 | 175 | 181 | 8 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)|World / shred by cell type and Timepoint | 6.70e-07 | 177 | 181 | 8 | 05c57578142a6662f18b294d5cc11e6efd6b0f8e | |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 7.00e-07 | 178 | 181 | 8 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.30e-07 | 179 | 181 | 8 | 6718cadcc2d3b64717ed84244ef1242d392662dc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-07 | 180 | 181 | 8 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.27e-07 | 182 | 181 | 8 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.62e-07 | 183 | 181 | 8 | a716b446c2bf5aa294b8f580aa845098fae76354 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.36e-07 | 185 | 181 | 8 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.19e-06 | 191 | 181 | 8 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.24e-06 | 192 | 181 | 8 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.39e-06 | 195 | 181 | 8 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.44e-06 | 196 | 181 | 8 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.50e-06 | 197 | 181 | 8 | 491e12a5fca06b86443c0173f5fa750ea3b8a715 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.50e-06 | 197 | 181 | 8 | 8e655db7c6f04d49927a1f0a75178e5955b4af08 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.56e-06 | 198 | 181 | 8 | 5f0964c3aa7e1dc52cbb46e754078920b65bcb88 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.56e-06 | 198 | 181 | 8 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.62e-06 | 199 | 181 | 8 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 1.62e-06 | 199 | 181 | 8 | 5c8b847b794b3e88722f5b841f2539a27251106c | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1-28|World / Primary Cells by Cluster | 1.62e-06 | 199 | 181 | 8 | 787688b68ae5d8768c0a24673ae07ab07616764a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.62e-06 | 199 | 181 | 8 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.62e-06 | 199 | 181 | 8 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1|World / Primary Cells by Cluster | 1.62e-06 | 199 | 181 | 8 | 72823f26ecabcae1b514b7629cfce010c97b929a | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 1.62e-06 | 199 | 181 | 8 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.62e-06 | 199 | 181 | 8 | ca17e8c0f5bc2c41ce28351a7418d934404e563b | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.62e-06 | 199 | 181 | 8 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.62e-06 | 199 | 181 | 8 | d8f904f531bfe091b7d8caaa147ea4a03d627995 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.62e-06 | 199 | 181 | 8 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.68e-06 | 200 | 181 | 8 | 9c03a8da12d29618f72c429836c1d1bd84a78b12 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.68e-06 | 200 | 181 | 8 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Monophasic_Synovial_Sarcoma-5|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.22e-06 | 93 | 181 | 6 | 3e05ea0f8f4a7cdb78a596f47d563dc3c94d4d8e | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.77e-06 | 163 | 181 | 7 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-06 | 163 | 181 | 7 | 3f434015c0cbefb31eeda133c34f75384c5f7e22 | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 4.77e-06 | 163 | 181 | 7 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.04e-06 | 169 | 181 | 7 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.28e-06 | 170 | 181 | 7 | 5319f73cff64f2bb67472c7156ee1d0f006c6fc0 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.05e-06 | 173 | 181 | 7 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.05e-06 | 173 | 181 | 7 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.32e-06 | 174 | 181 | 7 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.32e-06 | 174 | 181 | 7 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.32e-06 | 174 | 181 | 7 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.32e-06 | 174 | 181 | 7 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | Club-club-15|World / Class top | 7.59e-06 | 175 | 181 | 7 | ca9d012f520f697c7450ec6958a015e20538a6a8 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.59e-06 | 175 | 181 | 7 | 0b1aaa028ba844d4bcb4509fdab8bee648373935 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 8.80e-06 | 179 | 181 | 7 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.13e-06 | 180 | 181 | 7 | ed4966765a6b25456f68185cf0648c4a3a21d7fe | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.46e-06 | 181 | 181 | 7 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.46e-06 | 181 | 181 | 7 | f83565f09dd971c5cad2704a4a86bca0accd955e | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.02e-05 | 183 | 181 | 7 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-05 | 183 | 181 | 7 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.05e-05 | 184 | 181 | 7 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 1.09e-05 | 185 | 181 | 7 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.09e-05 | 185 | 181 | 7 | 6aeae77a087d695b1e58c5f63265e7113aa2e343 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 187 | 181 | 7 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 187 | 181 | 7 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 187 | 181 | 7 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 187 | 181 | 7 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-05 | 188 | 181 | 7 | 95d0a796d62ce6d121e2028c378faffc14b35275 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 125 | 181 | 6 | 35042ed43045dddc341b76cc5f9fe31b5ba0abb8 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.25e-05 | 189 | 181 | 7 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 126 | 181 | 6 | 4eeea015efe17e0aae5bd76b71fa70b5149dfada | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-05 | 190 | 181 | 7 | cd37ccd30c27cf65eda0a9165f35b7672f5acaf6 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 191 | 181 | 7 | 239300ff76f2c855b2b04d3002461158be90a01b | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.34e-05 | 191 | 181 | 7 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.34e-05 | 191 | 181 | 7 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.39e-05 | 192 | 181 | 7 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.39e-05 | 192 | 181 | 7 | 026f3e38970bea1e6e8d76a4e2becdfb8484b2ff | |
| ToppCell | Proliferating|World / shred by cell class for mouse tongue | 1.39e-05 | 192 | 181 | 7 | f081f3f957cc782294e118fcc1055f6a4264ee98 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 193 | 181 | 7 | a332dfdcc48c405020014e644aa4d14fda98cc86 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 1.43e-05 | 193 | 181 | 7 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.43e-05 | 193 | 181 | 7 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | (3)_Chondrocytes-(33)_Chondro-prol/rest|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.48e-05 | 194 | 181 | 7 | c093c5e161b97ad770bfbaad3023eba4537101b5 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.48e-05 | 194 | 181 | 7 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.48e-05 | 194 | 181 | 7 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.53e-05 | 195 | 181 | 7 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 1.53e-05 | 195 | 181 | 7 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-05 | 195 | 181 | 7 | 742c82c86487314cdb3178012004adb1164bcbdb | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.53e-05 | 195 | 181 | 7 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.59e-05 | 196 | 181 | 7 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.59e-05 | 196 | 181 | 7 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.59e-05 | 196 | 181 | 7 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.59e-05 | 196 | 181 | 7 | 62b2de1d38a99ab23211bf51595845f8a1fdb7d2 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.64e-05 | 197 | 181 | 7 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.64e-05 | 197 | 181 | 7 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | Healthy/Control-T/NK_proliferative|World / Disease group and Cell class | 1.64e-05 | 197 | 181 | 7 | 4a4d3083938783d6f5b87da02f10e501917da0b4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.64e-05 | 197 | 181 | 7 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.64e-05 | 197 | 181 | 7 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.69e-05 | 198 | 181 | 7 | 1fa213e79d828bff6465bde116536dd1b80d94e0 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 1.69e-05 | 198 | 181 | 7 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 1.69e-05 | 198 | 181 | 7 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| Drug | BAS 012416453; Down 200; 38uM; PC3; HT_HG-U133A | RANGAP1 ACACB NCKAP1 RTEL1 BAZ1B CEP164 KLHL9 SLC8B1 LRRC14 ANKRD12 | 2.57e-06 | 194 | 174 | 10 | 6876_DN |
| Drug | Hydrocortisone base [50-23-7]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.09e-06 | 198 | 174 | 10 | 5284_UP | |
| Drug | C19H22O2 | 7.26e-06 | 17 | 174 | 4 | CID000104880 | |
| Drug | 3-aminobenzoic acid | 8.80e-06 | 37 | 174 | 5 | CID000007419 | |
| Drug | Antigens, Polyomavirus Transforming | KNTC1 EARS2 ZGRF1 FBXL14 CASP3 BAZ1B LRRC40 DEPDC1 TTBK2 ODF2L PIGA ATXN7 ASB3 ASPM LRRC14 CDC25B PARP12 | 1.54e-05 | 668 | 174 | 17 | ctd:D000952 |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.62e-05 | 190 | 174 | 9 | 6979_UP | |
| Drug | Dacarbazine [4342-03-4]; Up 200; 22uM; PC3; HT_HG-U133A | 2.16e-05 | 197 | 174 | 9 | 4480_UP | |
| Drug | Colistin sulfate [1264-72-8]; Down 200; 3uM; PC3; HT_HG-U133A | 2.16e-05 | 197 | 174 | 9 | 4212_DN | |
| Drug | SR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.25e-05 | 198 | 174 | 9 | 4977_UP | |
| Drug | Cisapride [81098-60-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.25e-05 | 198 | 174 | 9 | 3305_DN | |
| Disease | Breast Cancer, Familial | 2.15e-05 | 30 | 162 | 4 | C0346153 | |
| Disease | Malignant neoplasm of breast | PPM1D SYNE1 CYP19A1 FRMPD1 TRMT11 LHCGR CNNM4 C5orf34 NLRP9 NLRP14 BRCA2 NUP133 NLRC5 ZFYVE26 ATM PLD2 LRBA CYB5R4 | 2.71e-05 | 1074 | 162 | 18 | C0006142 |
| Disease | ribulose-phosphate 3-epimerase measurement | 8.95e-05 | 3 | 162 | 2 | EFO_0802025 | |
| Disease | Colorectal Carcinoma | EVC2 SYNE1 PEG3 ERI2 KCNB2 PREX2 LRRC47 KCNQ5 TIAM1 CSRNP3 CCNB3 KDM2A HDC | 1.42e-04 | 702 | 162 | 13 | C0009402 |
| Disease | nevus count, cutaneous melanoma | 1.49e-04 | 91 | 162 | 5 | EFO_0000389, EFO_0004632 | |
| Disease | caspase-3 measurement | 1.78e-04 | 4 | 162 | 2 | EFO_0008070 | |
| Disease | breast cancer (is_implicated_in) | 1.86e-04 | 150 | 162 | 6 | DOID:1612 (is_implicated_in) | |
| Disease | BREAST CANCER | 2.01e-04 | 21 | 162 | 3 | 114480 | |
| Disease | dual specificity mitogen-activated protein kinase kinase 1 measurement | 2.96e-04 | 5 | 162 | 2 | EFO_0020335 | |
| Disease | tax1-binding protein 3 measurement | 2.96e-04 | 5 | 162 | 2 | EFO_0802120 | |
| Disease | Malignant tumor of breast | 4.31e-04 | 27 | 162 | 3 | cv:C0006142 | |
| Disease | Breast neoplasm | 4.31e-04 | 27 | 162 | 3 | cv:C1458155 | |
| Disease | Familial cancer of breast | 4.31e-04 | 27 | 162 | 3 | cv:C0346153 | |
| Disease | vital capacity | KNTC1 ZBTB38 UNC5B SYNE1 CYP19A1 FRMPD1 WDR26 DST LRRIQ1 KCNQ5 EDAR SLMAP SYCP1 KDM2A LRBA DOT1L FBXL20 | 4.76e-04 | 1236 | 162 | 17 | EFO_0004312 |
| Disease | cutaneous melanoma | 5.58e-04 | 121 | 162 | 5 | EFO_0000389 | |
| Disease | Crohn's disease (is_implicated_in) | 5.91e-04 | 30 | 162 | 3 | DOID:8778 (is_implicated_in) | |
| Disease | X-23641 measurement | 6.18e-04 | 7 | 162 | 2 | EFO_0800854 | |
| Disease | infertility (implicated_via_orthology) | 6.18e-04 | 7 | 162 | 2 | DOID:5223 (implicated_via_orthology) | |
| Disease | Subarachnoid Hemorrhage, Aneurysmal | 8.21e-04 | 8 | 162 | 2 | C0751530 | |
| Disease | Subarachnoid Hemorrhage, Spontaneous | 8.21e-04 | 8 | 162 | 2 | C0472383 | |
| Disease | helix rolling | 8.21e-04 | 8 | 162 | 2 | EFO_0007670 | |
| Disease | female breast cancer (is_implicated_in) | 8.21e-04 | 8 | 162 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | Subarachnoid Hemorrhage, Intracranial | 8.21e-04 | 8 | 162 | 2 | C0795688 | |
| Disease | Perinatal Subarachnoid Hemorrhage | 8.21e-04 | 8 | 162 | 2 | C0270192 | |
| Disease | Spinocerebellar Ataxia Type 2 | 8.58e-04 | 34 | 162 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 8.58e-04 | 34 | 162 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 8.58e-04 | 34 | 162 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 8.58e-04 | 34 | 162 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 8.58e-04 | 34 | 162 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 8.58e-04 | 34 | 162 | 3 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 4 | 9.34e-04 | 35 | 162 | 3 | C0752122 | |
| Disease | endometrial cancer (is_implicated_in) | 1.02e-03 | 36 | 162 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | Subarachnoid Hemorrhage | 1.05e-03 | 9 | 162 | 2 | C0038525 | |
| Disease | Glioma | 1.37e-03 | 87 | 162 | 4 | C0017638 | |
| Disease | Inherited neuropathies | 1.38e-03 | 40 | 162 | 3 | C0598589 | |
| Disease | age at onset, Myopia | 1.46e-03 | 150 | 162 | 5 | EFO_0004847, HP_0000545 | |
| Disease | Diabetic Retinopathy | 1.59e-03 | 11 | 162 | 2 | C0011884 | |
| Disease | outer ear morphology trait | 1.91e-03 | 12 | 162 | 2 | EFO_0007664 | |
| Disease | multiple sclerosis (is_marker_for) | 2.49e-03 | 49 | 162 | 3 | DOID:2377 (is_marker_for) | |
| Disease | Hypermetropia | 2.54e-03 | 103 | 162 | 4 | HP_0000540 | |
| Disease | Fibrosis | 2.64e-03 | 50 | 162 | 3 | C0016059 | |
| Disease | Cirrhosis | 2.64e-03 | 50 | 162 | 3 | C1623038 | |
| Disease | posterior thigh muscle volume | 3.00e-03 | 15 | 162 | 2 | EFO_0020931 | |
| Disease | C-X-C motif chemokine 10 measurement | 3.11e-03 | 109 | 162 | 4 | EFO_0008056 | |
| Disease | galectin-3 measurement | 3.42e-03 | 16 | 162 | 2 | EFO_0008137 | |
| Disease | dental caries | 3.80e-03 | 187 | 162 | 5 | EFO_0003819 | |
| Disease | high altitude adaptation | 3.86e-03 | 17 | 162 | 2 | EFO_0009105 | |
| Disease | diabetic neuropathy (biomarker_via_orthology) | 3.86e-03 | 17 | 162 | 2 | DOID:9743 (biomarker_via_orthology) | |
| Disease | leukemia (implicated_via_orthology) | 4.82e-03 | 19 | 162 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of prostate | 5.33e-03 | 20 | 162 | 2 | C0007112 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ETSHICDRNLSISTK | 666 | A8K979 | |
| HCENRLSLSEILSNI | 506 | Q52LR7 | |
| HLLSCSRDNTLKVID | 516 | Q8NAA4 | |
| SETHRSCLLRKLEES | 491 | Q8IYX3 | |
| DTLISISRLQHLLSC | 351 | Q6Y288 | |
| NEILRGSSHLCSLLK | 731 | Q9NQ75 | |
| CLQLHEAKRLDSATA | 351 | P28330 | |
| TNSTAVHRLELLLKC | 526 | O94812 | |
| TSEEKLQILTALCHR | 741 | Q9UIG0 | |
| CHTSERKEILSLDKL | 171 | Q16589 | |
| TSVLLLRSCKTLTHE | 241 | Q86W34 | |
| DASRLHLELDCTKFS | 686 | Q8TEK3 | |
| KLESLVLTHLSRCDS | 1636 | Q6UB98 | |
| EDHSKRSSFVCVLLS | 106 | P42574 | |
| LTSLSKCSLHEQKRR | 481 | Q6DHV5 | |
| SSISCLRHRETIKSV | 891 | Q6DHV5 | |
| HKRLCLSSEDDQSID | 51 | Q9Y222 | |
| SDNTISRRICTIAKH | 111 | Q8TCP9 | |
| KTISLLSCHSDDLIN | 1081 | Q8IZT6 | |
| ILELKSASCSHQLLA | 1041 | Q96MI9 | |
| NCTSRLDAHKVLSAL | 161 | P01019 | |
| LSLKKCSNHEEVSLL | 176 | Q8WWL7 | |
| SADDNLKTRAECLLH | 361 | Q92617 | |
| VHLTCTSSKTAREDL | 506 | P24386 | |
| ILAAALTECHRKSSA | 161 | P46060 | |
| TSESHLSCLKQDILN | 31 | Q9ULJ1 | |
| SADDNLKTRAECLLH | 361 | F8W0I5 | |
| TILDCHAATLQRKAD | 1086 | O00763 | |
| HRSTIVDCLKDLDVS | 346 | O43747 | |
| LIRDAATLILSQHCT | 466 | P19113 | |
| VSSDKLALCHLELTR | 76 | O14526 | |
| TRLLLCEHAEKLSAA | 636 | Q8WUM0 | |
| NKESLSSVCGLRLLH | 611 | P56730 | |
| LTEESFKACHLTLTL | 241 | Q6ZSA7 | |
| STLHCQGTALLDKTR | 681 | P22888 | |
| TETHLQLACAKLISR | 56 | Q49AS3 | |
| QILHDTLSEACLRIS | 2716 | Q9UKN7 | |
| EKSHSRSELLQQALC | 5596 | Q03001 | |
| ELETTLLERSKCHES | 131 | O76014 | |
| LTSQTKLHEDLCEKR | 356 | Q8N1G4 | |
| LCEKRTAATLATHEL | 366 | Q8N1G4 | |
| EHTKLASSCLLILEF | 151 | Q9NR82 | |
| ELEATLLERSKCHES | 131 | O76015 | |
| CLLSLVHLAREKSAT | 301 | Q9UNE0 | |
| LSHLILDSSSKICDL | 426 | Q9NYF5 | |
| CLHRTELETKLKSLE | 196 | Q6KB66 | |
| DISLTKLDNHCELLS | 1311 | Q9P219 | |
| SLSLAEKSILHEECI | 561 | Q8WYN3 | |
| CDHLSDEISITTLRL | 441 | Q86V87 | |
| LALKALSLIHSRTNC | 481 | Q99502 | |
| STECLLLSLLHREKN | 341 | Q5TB30 | |
| LTITNCVLLESDLKH | 301 | P0DUQ1 | |
| LVERIITCKHSSDTN | 261 | Q8N5J2 | |
| ERLAFVLSSNSLKHC | 196 | Q9P2J3 | |
| VLSSNSLKHCTELEL | 201 | Q9P2J3 | |
| IELQSLLATKHSLEC | 316 | Q7Z3Y8 | |
| LLATKHSLECSLTET | 321 | Q7Z3Y8 | |
| IELQSLLATKHSLEC | 311 | Q7Z3Z0 | |
| LLATKHSLECSLTET | 316 | Q7Z3Z0 | |
| TKSACTQILESHSRE | 1006 | Q86UK5 | |
| SKSHVSRAVLELCLA | 536 | P50851 | |
| SRCLHDETQKSVSLL | 21 | A0A1B0GTW7 | |
| CETLKSLTHLDLHSN | 1031 | Q5S007 | |
| LRSKSLCHDEIENLL | 371 | P30305 | |
| SVILLDSICRSLQLH | 66 | P50748 | |
| SADDNLKTRAECLLH | 361 | A8MRT5 | |
| CQAELKRLSEHLTES | 421 | Q96PP9 | |
| ALVSNRSLTHLCLSN | 946 | P59047 | |
| SLSCVISRSRHLKSL | 1056 | P59047 | |
| ENCAKALTLRIHDSL | 476 | O15297 | |
| LRLSCVDTHANELTL | 186 | O76002 | |
| VSSLLTNHLARATEC | 1356 | Q9Y4D8 | |
| SADDNLKTRAECLLH | 361 | C9JG80 | |
| TLTTLLEKVEGCRHL | 161 | Q8IYI6 | |
| LKSLNLRSCRHLSDV | 171 | Q8N1E6 | |
| DCQKLTDLSLKHISR | 211 | Q8N1E6 | |
| TRILICTHSNSAADL | 691 | P42694 | |
| IRLSLKSNVTSLDCH | 351 | Q86Y91 | |
| SLTCKTHSLTQRRAV | 361 | O15265 | |
| LSLESCSLQDVLLHR | 636 | Q6XUX3 | |
| RVCKETFLHSSALIE | 566 | Q9GZU2 | |
| LDVSHNCLSDLKSAI | 1086 | Q96JM4 | |
| LTCTDLATLTNILEH | 646 | Q86WI3 | |
| DKLHTALSELCFSIN | 676 | Q9Y2A7 | |
| KIERILCSESASTFH | 326 | Q9H0J9 | |
| SLQSRCSISKISEHV | 401 | O43613 | |
| SVHQNLKESLDRCLL | 681 | Q13315 | |
| SLTHLCRLEIRSSLK | 461 | Q9Y575 | |
| LGTRKTISECLLHLQ | 426 | Q9H5Z6 | |
| QITRKACEHFISDLS | 1131 | Q9Y2K7 | |
| LGKLRDCNTHESLLE | 61 | Q92953 | |
| HELKLSIICLNSSRL | 771 | Q8NF50 | |
| ILKTTSEECRDADLH | 1151 | P51587 | |
| SAIENTKLHCDSLET | 81 | Q5T0U0 | |
| TKLHCDSLETQIKSL | 86 | Q5T0U0 | |
| SSSLVIHKARSNLCL | 351 | Q96HJ3 | |
| VTVCAESLKTHLDRL | 161 | P11511 | |
| CKLHQERDESTLATS | 271 | Q6IN97 | |
| KCSSALRLAALHIQE | 301 | Q5SYB0 | |
| LKAAHELCDSILQSR | 196 | Q8TF46 | |
| HSEKSDAACQTLLSL | 146 | Q6PGQ7 | |
| KLCSILHTDSLAEVL | 186 | Q53FE4 | |
| LFDNKSLTTECHLLD | 791 | Q15398 | |
| TELALVLSLCSHRVN | 96 | Q8IZC6 | |
| GTTHDLLDICLKRAT | 31 | Q13867 | |
| AAEKNHTSCLVRSSL | 126 | Q8N5U1 | |
| TKHRLCSQESSVSAL | 6 | Q8IYD9 | |
| EELKDEATSCSLHRS | 56 | Q9HBE5 | |
| EHCSLLEATKLLASI | 306 | Q9C0E4 | |
| QEERDCHLKTISSLK | 576 | Q4V328 | |
| KTSEILHDIDCLLSN | 621 | Q96MH7 | |
| NSITLCADVSHKLLR | 276 | Q7Z3Z3 | |
| LQRLLKSNSHLSEEC | 176 | Q9H4I8 | |
| KSLILTALQRETEHC | 81 | Q8TEX9 | |
| LKNRTLDEHLTCLLL | 61 | H0Y7S4 | |
| TITNCVLLESDLKHL | 206 | H0Y7S4 | |
| TKTRALTVAHELLCN | 361 | Q03701 | |
| EHNSILQSLLETLKC | 41 | Q07866 | |
| LSLCRKLEVLSLSHN | 136 | A6NM36 | |
| KLEVLSLSHNCLSQL | 141 | A6NM36 | |
| RLKHLDCNSNLLETI | 221 | Q9H9A6 | |
| SADDNLKTRAECLLH | 361 | A6NJU9 | |
| GCLLQISRSHTEVKL | 506 | Q6J4K2 | |
| ELFHSIQRTCLDLSK | 61 | Q05084 | |
| DVRHLLKLACTDTTV | 181 | Q5JRS4 | |
| DRFISLLKDIHVTSC | 226 | Q6ZN16 | |
| EQILSHRLKEISQSC | 71 | Q96NL0 | |
| EQAHSCSTLSLLSEK | 851 | Q9NZ71 | |
| STTIEKLRAICLDHA | 1051 | Q93008 | |
| SNCEQKLSSHTSRRL | 396 | Q7Z4G4 | |
| LLQEVEHQLRSCSKS | 221 | O94972 | |
| EHQLRSCSKSELISK | 226 | O94972 | |
| TSTINELNHCLSLRT | 96 | P07814 | |
| CHVTLKELRAAIDST | 1101 | Q8NF91 | |
| RVVTAAHCLDSLSEK | 81 | Q7RTY7 | |
| ALLDSSHSELKCDIS | 216 | P29590 | |
| RLQVLSLSHCELITD | 326 | Q96IG2 | |
| LITDASLEHLKSCHS | 366 | Q96IG2 | |
| TNCVLLESDLKHLSK | 301 | Q5VT98 | |
| LTITNCVLLESDLKH | 301 | A6NGN4 | |
| LTITNCVLLESDLKH | 301 | A3QJZ7 | |
| TLSRLAHRLKNACTA | 316 | Q9BUU2 | |
| HIRGKCSVTLLNETE | 121 | Q13330 | |
| LSSCSHKTISIFEER | 91 | Q9NUC0 | |
| ISKEDVTHDTRLFCL | 281 | Q7L1T6 | |
| NLLIISTVLSCSRLH | 41 | Q8NGC5 | |
| SSETKLLQHLLEACG | 146 | Q53H96 | |
| LTQVTCHSALLDLEK | 336 | Q5JPH6 | |
| CKAIRNTSTSLHLQL | 381 | Q9BY15 | |
| LEKEHSAELERLCSS | 766 | Q9UPV0 | |
| SAELERLCSSLEAKH | 771 | Q9UPV0 | |
| IRTLNSTLKCKEHDL | 821 | G9CGD6 | |
| TLHKSTSCLELTKDL | 101 | Q6P4Q7 | |
| SLSQSDIRHLCETLK | 696 | Q7RTR0 | |
| LTNKLLTVSLCDTNH | 166 | P37287 | |
| LTITNCVLLESDLKH | 301 | O60810 | |
| LEGHLDQLLSCLKTS | 281 | Q5VXH4 | |
| ITNCVLLESDLKHLS | 301 | Q5VXH4 | |
| CLRVAASTLLSLHKV | 41 | Q9UM82 | |
| HKCSVQTLLRSELSA | 206 | Q13114 | |
| QTLLRSELSAHLSEC | 211 | Q13114 | |
| SLHSESKVLILFCNL | 391 | Q70EL4 | |
| CSASEKSHQERDLIK | 606 | Q8NEP9 | |
| HSDILSLKNQCLATL | 41 | Q99973 | |
| TARDTLELICKTHQL | 786 | Q13009 | |
| ELDIKLQESSCTHLL | 196 | Q6NUQ1 | |
| HSIRSDSEDICLFTK | 86 | O76021 | |
| STLLNHTSDRICDKS | 201 | P50443 | |
| NIHKTNLCDLITSLL | 296 | P50443 | |
| LKNTELTSHCNKLSL | 511 | Q15431 | |
| LTSHCNKLSLENKEL | 516 | Q15431 | |
| HLSISADCQDLLKRL | 231 | Q96PN8 | |
| ERSLSNTEDECTHLK | 276 | Q14BN4 | |
| EKTLKECSSLEHLLS | 386 | Q14BN4 | |
| TECHSLKRENVLLSS | 671 | Q14BN4 | |
| LTITNCVLLESDLKH | 301 | P0DUQ2 | |
| KDTDRIICSTNILHK | 261 | Q8IV42 | |
| LLSNIRSQCISHTAL | 456 | O95155 | |
| EKLSRGQHCIEISSL | 791 | Q6IQ55 | |
| DCLVLATAKHSRELN | 866 | Q8TEQ6 | |
| LEGHLDQLLSCLKTS | 281 | Q5TYX0 | |
| ITNCVLLESDLKHLS | 301 | Q5TYX0 | |
| LKHLSLLTTLSNRVC | 206 | P02774 | |
| LTITNCVLLESDLKH | 301 | O60813 | |
| SALETINRCLTKHLE | 81 | Q9UH36 | |
| LQSKFSALCSERIEH | 881 | Q70Z35 | |
| LERHSLASTELTCKI | 796 | Q8IZJ1 | |
| TCSSLLKDILRLAEH | 91 | Q8IVP9 | |
| ISILKSLCEHSTALD | 826 | Q86YA3 | |
| SLLNENHREKTTLCV | 51 | Q16401 | |
| HTLQDVSTCETKELL | 1731 | Q5VWN6 | |
| TICISSHVLELDDLK | 66 | Q8NAP3 | |
| NLDSVSLLIDHVCSR | 326 | Q9H7D7 | |
| NTLILRCKDTATAHS | 276 | Q13425 | |
| LFSSHKLIECDTLSR | 1691 | Q5T5U3 | |
| RIDTSHRSLILKCSS | 281 | O14939 | |
| HQRSLDTASVDLCIK | 91 | Q9NVH6 | |
| HCQSLESAKRLLQTL | 376 | Q68DK2 | |
| EKTHALLQTCSTESL | 6 | Q0VDI3 | |
| IQIELHFRSTKDSSC | 2376 | Q5THJ4 | |
| TLLHLELTECQLADT | 366 | Q15048 | |
| SLLRRTHLCSLSKSD | 61 | Q9H400 | |
| THLCSLSKSDTRLHE | 66 | Q9H400 | |
| LLNEETRSHLEKSLC | 566 | P59046 | |
| SLALISNKRLTHLCL | 836 | Q86W24 |